1,736
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?

, &
Pages 67-71 | Accepted 30 Apr 2013, Published online: 07 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tasneem Lokhandwala, Nancy Smith, Catarina Sternhufvud, Elisabeth Sörstadius, Won Chan Lee & Jayanti Mukherjee. (2016) A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs loose-dose combination of oral anti-diabetes drugs. Journal of Medical Economics 19:3, pages 203-212.
Read now

Articles from other publishers (3)

Clara K. Chow & Qingtao Meng. (2019) Polypills for primary prevention of cardiovascular disease. Nature Reviews Cardiology 16:10, pages 602-611.
Crossref
Valentina Perrone, Chiara Veronesi, Marco Gambera, Giulio Nati, Francesco Perone, Paola Fausta Tagliabue, Luca Degli Esposti & Massimo Volpe. (2019) Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy. High Blood Pressure & Cardiovascular Prevention 26:5, pages 399-404.
Crossref
Antonio L. Doadrio, Jos? M. S?nchez-Montero, Juan C. Doadrio, Antonio J. Salinas & Mar?a Vallet-Reg?. (2017) Mesoporous silica nanoparticles as a new carrier methodology in the controlled release of the active components in a polypill. European Journal of Pharmaceutical Sciences 97, pages 1-8.
Crossref